BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 12911550)

  • 1. The quality of life and cost utility of home nocturnal and conventional in-center hemodialysis.
    McFarlane PA; Bayoumi AM; Pierratos A; Redelmeier DA
    Kidney Int; 2003 Sep; 64(3):1004-11. PubMed ID: 12911550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost savings of home nocturnal versus conventional in-center hemodialysis.
    McFarlane PA; Pierratos A; Redelmeier DA
    Kidney Int; 2002 Dec; 62(6):2216-22. PubMed ID: 12427148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An operating cost comparison between conventional and home quotidian hemodialysis.
    Kroeker A; Clark WF; Heidenheim AP; Kuenzig L; Leitch R; Meyette M; Muirhead N; Ryan H; Welch R; White S; Lindsay RM
    Am J Kidney Dis; 2003 Jul; 42(1 Suppl):49-55. PubMed ID: 12830444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic considerations in frequent home hemodialysis.
    McFarlane P; Komenda P
    Semin Dial; 2011; 24(6):678-83. PubMed ID: 22122513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing hemodialysis costs: conventional and quotidian home hemodialysis in Canada.
    McFarlane PA
    Semin Dial; 2004; 17(2):118-24. PubMed ID: 15043613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-Effectiveness of High Dose Hemodialysis in Comparison to Conventional In-Center Hemodialysis in the Netherlands.
    Beby AT; Cornelis T; Zinck R; Liu FX
    Adv Ther; 2016 Nov; 33(11):2032-2048. PubMed ID: 27664108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose hemodialysis versus conventional in-center hemodialysis: a cost-utility analysis from a UK payer perspective.
    Liu FX; Treharne C; Arici M; Crowe L; Culleton B
    Value Health; 2015 Jan; 18(1):17-24. PubMed ID: 25595230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nocturnal haemodialysis: an Australian cost comparison with conventional satellite haemodialysis.
    Agar JW; Knight RJ; Simmonds RE; Boddington JM; Waldron CM; Somerville CA
    Nephrology (Carlton); 2005 Dec; 10(6):557-70. PubMed ID: 16354238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost of starting and maintaining a large home hemodialysis program.
    Komenda P; Copland M; Makwana J; Djurdjev O; Sood MM; Levin A
    Kidney Int; 2010 Jun; 77(11):1039-45. PubMed ID: 20375983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health economic evaluations: the special case of end-stage renal disease treatment.
    Winkelmayer WC; Weinstein MC; Mittleman MA; Glynn RJ; Pliskin JS
    Med Decis Making; 2002; 22(5):417-30. PubMed ID: 12365484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost analysis of dialysis treatments for end-stage renal disease (ESRD).
    Goeree R; Manalich J; Grootendorst P; Beecroft ML; Churchill DN
    Clin Invest Med; 1995 Dec; 18(6):455-64. PubMed ID: 8714789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct and indirect costs of end-stage renal disease patients in the first and second years after initiation of nocturnal home haemodialysis, hospital haemodialysis and peritoneal dialysis.
    Wong CKH; Chen J; Fung SKS; Mok MMY; Cheng YL; Kong I; Lo WK; Lui SL; Chan TM; Lam CLK
    Nephrol Dial Transplant; 2019 Sep; 34(9):1565-1576. PubMed ID: 30668781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-sectional comparison of quality of life and illness intrusiveness in patients who are treated with nocturnal home hemodialysis versus peritoneal dialysis.
    Fong E; Bargman JM; Chan CT
    Clin J Am Soc Nephrol; 2007 Nov; 2(6):1195-200. PubMed ID: 17928469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of home nocturnal hemodialysis on end-stage renal disease therapies: a decision analysis.
    McFarlane PA; Bayoumi AM; Pierratos A; Redelmeier DA
    Kidney Int; 2006 Mar; 69(5):798-805. PubMed ID: 16407887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effectiveness and cost-effectiveness of the implantable miniature telescope.
    Brown GC; Brown MM; Lieske HB; Lieske PA; Brown KS; Lane SS
    Ophthalmology; 2011 Sep; 118(9):1834-43. PubMed ID: 21723614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic evaluation of palliative management versus peritoneal dialysis and hemodialysis for end-stage renal disease: evidence for coverage decisions in Thailand.
    Teerawattananon Y; Mugford M; Tangcharoensathien V
    Value Health; 2007; 10(1):61-72. PubMed ID: 17261117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of acute kidney injury in the intensive care unit: a cost-effectiveness analysis of daily vs alternate-day hemodialysis.
    Desai AA; Baras J; Berk BB; Nakajima A; Garber AM; Owens D; Chertow GM
    Arch Intern Med; 2008 Sep; 168(16):1761-7. PubMed ID: 18779463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic evaluation of dialysis therapies.
    Klarenbach S; Manns B
    Semin Nephrol; 2009 Sep; 29(5):524-32. PubMed ID: 19751898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-utility analysis of cochlear implants in Korea using different measures of utility.
    Lee HY; Park EC; Kim HJ; Choi JY; Kim HN
    Acta Otolaryngol; 2006 Aug; 126(8):817-23. PubMed ID: 16846923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic evaluation of frequent home nocturnal hemodialysis based on a randomized controlled trial.
    Klarenbach S; Tonelli M; Pauly R; Walsh M; Culleton B; So H; Hemmelgarn B; Manns B
    J Am Soc Nephrol; 2014 Mar; 25(3):587-94. PubMed ID: 24231665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.